Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice
2025 · ESMO Gastrointestinal Oncology · 10 citations
https://doi.org/10.1016/j.esmogo.2024.100128
T
Takeshi Aoyama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
214
Citations
9
h-index
9
i10-index
Takeshi Aoyama is an academic researcher from Japanese Foundation For Cancer Research. The author has contributed to research in topics: Nausea and vomiting management & Colorectal Cancer Treatments and Studies & Chemotherapy-induced organ toxicity mitigation. The author has an h-index of 9, co-authored 45 publications.
ORCID: 0000-0002-0767-2606Papers by this author
worksRisk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy
2021 · PLoS ONE · 7 citations
https://doi.org/10.1371/journal.pone.0254726
Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
2023 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-023-28688-9
Extravasation associated with cancer drug therapy: multidisciplinary guideline of the Japanese Society of Cancer Nursing, Japanese Society of Medical Oncology, and Japanese Society of Pharmaceutical Oncology
2024 · ESMO Open · 6 citations
https://doi.org/10.1016/j.esmoop.2024.103932
Identification of high-risk age groups for cisplatin-induced nausea and vomiting in young patients with sarcoma
2025 · Journal of Pharmaceutical Health Care and Sciences · 0 citations
https://doi.org/10.1186/s40780-025-00490-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat